167 related articles for article (PubMed ID: 31550271)
1. Vitamin D treatment of peripheral blood mononuclear cells modulated immune activation and reduced susceptibility to HIV-1 infection of CD4+ T lymphocytes.
Gonzalez SM; Aguilar-Jimenez W; Trujillo-Gil E; Zapata W; Su RC; Ball TB; Rugeles MT
PLoS One; 2019; 14(9):e0222878. PubMed ID: 31550271
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D modulates the expression of HLA-DR and CD38 after in vitro activation of T-cells.
Villegas-Ospina S; Aguilar-Jimenez W; Gonzalez SM; Rugeles MT
Horm Mol Biol Clin Investig; 2017 Mar; 29(3):93-103. PubMed ID: 28222027
[TBL] [Abstract][Full Text] [Related]
3. High Expression of Antiviral and Vitamin D Pathway Genes Are a Natural Characteristic of a Small Cohort of HIV-1-Exposed Seronegative Individuals.
Aguilar-Jimenez W; Saulle I; Trabattoni D; Vichi F; Lo Caputo S; Mazzotta F; Rugeles MT; Clerici M; Biasin M
Front Immunol; 2017; 8():136. PubMed ID: 28243241
[TBL] [Abstract][Full Text] [Related]
4. Calcitriol decreases HIV-1 transfer in vitro from monocyte-derived dendritic cells to CD4 + T cells, and downregulates the expression of DC-SIGN and SIGLEC-1.
Alvarez N; Gonzalez SM; Hernandez JC; Rugeles MT; Aguilar-Jimenez W
PLoS One; 2022; 17(7):e0269932. PubMed ID: 35802715
[TBL] [Abstract][Full Text] [Related]
5. Role of in vitro stimulation with lipopolysaccharide on T-cell activation in HIV-infected antiretroviral-treated patients.
Tincati C; Bellistrì GM; Ancona G; Merlini E; d'Arminio Monforte A; Marchetti G
Clin Dev Immunol; 2012; 2012():935425. PubMed ID: 22400042
[TBL] [Abstract][Full Text] [Related]
6. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
[TBL] [Abstract][Full Text] [Related]
7. Selective increase of activation antigens HLA-DR and CD38 on CD4+ CD45RO+ T lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Vereecken C; Vandenbruaene M; Vercauteren G; Colebunders RL; Gigase PL
Clin Exp Immunol; 1994 Mar; 95(3):436-41. PubMed ID: 7907956
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CD31 expression in CD4+ and CD8+T cell subpopulations in chronic untreated HIV infection.
Briceño O; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Chávez-Torres M; de la Barrera CA; Reyes-Terán G; Ávila-Ríos S
Immunol Lett; 2021 Jul; 235():22-31. PubMed ID: 33852965
[TBL] [Abstract][Full Text] [Related]
10. Precursor Forms of Vitamin D Reduce HIV-1 Infection In Vitro.
Aguilar-Jimenez W; Villegas-Ospina S; Gonzalez S; Zapata W; Saulle I; Garziano M; Biasin M; Clerici M; Rugeles MT
J Acquir Immune Defic Syndr; 2016 Dec; 73(5):497-506. PubMed ID: 27509245
[TBL] [Abstract][Full Text] [Related]
11. Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.
Zhang Y; de Lara C; Worth A; Hegedus A; Laamanen K; Beverley P; Macallan D
PLoS Pathog; 2013; 9(4):e1003310. PubMed ID: 23637601
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR expression on regulatory T cells is closely associated with the global immune activation in HIV-1 infected subjects naïve to antiretroviral therapy.
Xiao J; Qian KL; Cao QH; Qiu CL; Qiu C; Xue YL; Zhang XY; Zhong P; Xu JQ; Li MY; Wang Y
Chin Med J (Engl); 2011 Aug; 124(15):2340-6. PubMed ID: 21933566
[TBL] [Abstract][Full Text] [Related]
13. HLA-DR+ CD38+ CD4+ T lymphocytes have elevated CCR5 expression and produce the majority of R5-tropic HIV-1 RNA in vivo.
Meditz AL; Haas MK; Folkvord JM; Melander K; Young R; McCarter M; Mawhinney S; Campbell TB; Lie Y; Coakley E; Levy DN; Connick E
J Virol; 2011 Oct; 85(19):10189-200. PubMed ID: 21813616
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of R5-tropic HIV type-1 replication in CD4⁺ natural killer T cells by γδ T lymphocytes.
Omi K; Shimizu M; Watanabe E; Matsumura J; Takaku C; Shinya E; Takahashi H
Immunology; 2014 Apr; 141(4):596-608. PubMed ID: 24266436
[TBL] [Abstract][Full Text] [Related]
15. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.
Eller MA; Blom KG; Gonzalez VD; Eller LA; Naluyima P; Laeyendecker O; Quinn TC; Kiwanuka N; Serwadda D; Sewankambo NK; Tasseneetrithep B; Wawer MJ; Gray RH; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
PLoS One; 2011 Apr; 6(4):e18779. PubMed ID: 21526194
[TBL] [Abstract][Full Text] [Related]
16. HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurement.
Lubaki NM; Shepherd ME; Brookmeyer RS; Hon H; Quinn TC; Kashamuka M; Johnson M; Gottle R; Devers J; Lederman HM; Bollinger RC
J Acquir Immune Defic Syndr; 1999 Sep; 22(1):19-30. PubMed ID: 10534143
[TBL] [Abstract][Full Text] [Related]
17. Increased HLA-DR expression on peripheral blood monocytes in subsets of subjects with primary HIV infection is associated with elevated CD4 T-cell apoptosis and CD4 T-cell depletion.
Gascon RL; Narváez AB; Zhang R; Kahn JO; Hecht FM; Herndier BG; McGrath MS
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):146-53. PubMed ID: 12045676
[TBL] [Abstract][Full Text] [Related]
18. Semen protects CD4+ target cells from HIV infection but promotes the preferential transmission of R5 tropic HIV.
Balandya E; Sheth S; Sanders K; Wieland-Alter W; Lahey T
J Immunol; 2010 Dec; 185(12):7596-604. PubMed ID: 21059891
[TBL] [Abstract][Full Text] [Related]
19. Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.
Meng Q; Sayin I; Canaday DH; Mayanja-Kizza H; Baseke J; Toossi Z
PLoS One; 2016; 11(11):e0166954. PubMed ID: 27870882
[TBL] [Abstract][Full Text] [Related]
20. Low-level exposure to HIV induces virus-specific T cell responses and immune activation in exposed HIV-seronegative individuals.
Restrepo C; Rallón NI; del Romero J; Rodríguez C; Hernando V; López M; Peris A; Lozano S; Sempere-Ortells JM; Soriano V; Benito JM
J Immunol; 2010 Jul; 185(2):982-9. PubMed ID: 20543099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
